# FDA 483 - Norbitec GmbH - April 06, 2023

Source: https://www.globalkeysolutions.net/records/483/norbitec-gmbh/f295f9b4-df82-488f-b18c-8425cd81a60f

> FDA 483 for Norbitec GmbH on April 06, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Norbitec GmbH
- Inspection Date: 2023-04-06
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2023-04-06](https://www.globalkeysolutions.net/records/483/norbitec-gmbh/75bf548d-c8ac-4320-bb57-7ec51da04eb8)

## Related Officers

- [Nailing Zhang](https://www.globalkeysolutions.net/people/nailing-zhang/d3814d08-b799-4de1-b901-1b90da0e0178)
- [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.globalkeysolutions.net/companies/norbitec-gmbh/7a35a1cf-8ea9-4c18-b357-c7a5530fcd2b

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd